Publications by authors named "A Al-YOusef"
Objective: This systematic review and meta-analysis aimed to determine the implications of implant design on the outcomes of simultaneous guided bone regeneration (GBR) to correct dehiscence defects.
Methods: A structured search strategy was applied to MEDLINE (PubMed), Cochrane Library, and Embase, to identify prospective clinical trials involving implants with simultaneous GBR to correct dehiscence defects. Data regarding implant characteristics, GBR materials, as well as dehiscence defect dimensions at implant placement and surgical re-entry was collected.
Article Synopsis
- - The study investigates the differences in chronic kidney disease (CKD) management and characteristics between Kuwaiti citizens and expatriates, revealing that expatriates face restricted access to public health services and lower incomes, impacting their health outcomes.
- - Data from 2,610 CKD patients showed that Kuwaitis were older with slightly lower kidney function (eGFR), but exhibited better blood pressure and diabetes control compared to expatriates, who had overall higher kidney function but poorer management of diabetes and hypertension.
- - The conclusion emphasizes that CKD is predominantly caused by diabetes and hypertension, particularly in expatriates, and stresses the need for improved healthcare access, better treatment utilization, and more effective antihypertensive therapies for all patients.
Article Synopsis
- The study investigates the incidence and outcomes of acute kidney injury (AKI) in Kuwait, focusing on differences between Kuwaiti and non-Kuwaiti patients, who face limited access to healthcare.
- A total of 3,744 adult inpatients with AKI were analyzed from seven public hospitals in 2021, revealing that non-Kuwaitis were younger, had better kidney function at baseline, and a higher rate of AKI caused by community factors.
- Despite differences in demographics, there were no significant variations in mortality or kidney recovery rates between the two groups, with a high overall mortality rate of 34.4% among AKI patients within 30 days of hospitalization.
Article Synopsis
- The study evaluates the cost-effectiveness of Sodium zirconium cyclosilicate (SZC) compared to patiromer in managing serum potassium levels in patients with chronic kidney disease (CKD) and heart failure (HF) from a Kuwaiti healthcare perspective.
- A comprehensive simulation model was used to analyze the clinical outcomes and costs associated with both treatments over a lifetime horizon, using data from significant clinical trials and local hospital costs.
- Results indicate that SZC is generally a cost-saving treatment option for managing hyperkalemia, with potential savings ranging from KWD -60 to KWD -1,235, suggesting it should be considered as a viable treatment for CKD/HF patients in Kuwait.